EUDA Health Holdings Ltd EUDA
Nasdaq · XNAS · stock · Services-Health Services · website · IPO 2021-07-28
Chart by TradingView
4/9
Piotroski F — financial health
-129.19
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2022 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $6.8M | $4.0M | $3.7M | $3.8M | — |
| Gross profit | $3.0M | $762,155 | $842,075 | $869,999 | — |
| Operating income | -$2.5M | -$17.3M | -$4.0M | -$12.2M | -$2.0M |
| Net income | -$2.8M | -$15.4M | -$10.0M | -$24.9M | -$1.8M |
| Operating cash flow | -$2.4M | -$2.0M | -$3.2M | -$1.5M | -$1.0M |
| Free cash flow | -$2.5M | -$2.1M | — | -$1.5M | — |
| Total assets | $1.7M | $1.7M | $1.3M | $25.6M | $86.8M |
| Total liabilities | $6.0M | $4.3M | $8.8M | $29.1M | $4.7M |
| Shareholders' equity | -$4.3M | -$2.6M | -$7.5M | -$3.5M | -$3.7M |
| Ratios | |||||
| Gross margin | 43.9% | 19.0% | 22.7% | 23.1% | — |
| Operating margin | -36.3% | -432.2% | -106.9% | -324.6% | — |
| Net margin | -40.7% | -382.9% | -270.9% | -661.1% | — |
| FCF margin | -36.7% | -52.9% | — | -41.0% | — |
| Return on assets | -161.5% | -904.5% | -766.1% | -97.1% | -2.0% |
| Return on equity | 65.0% | 601.5% | 134.2% | 709.5% | 47.3% |
| Current ratio | 0.18 | 0.18 | 0.08 | 0.86 | — |
| Revenue growth | 70.0% | 8.2% | -1.5% | — | — |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -129.19 (distress)
- Working capital / assets -2.794
- Retained earnings / assets -30.802
- EBIT / assets -1.444
- Equity / liabilities -0.713
Sector peers
GOOG · MSFT · META · BABA · DIS · HCA · all Services →
Source: SEC EDGAR filings · CIK 0001847846 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.